Keyword: U.S. Department of Justice
With federal prosecutors laying waste to Insys' executive team, one big domino was still left to fall: Founder and former CEO John Kapoor.
WIth its megamerger with AbbVie nearing a close, Allergan will pay $300 million to settle claims against its Warner Chilcott and Watson businesses.
A federal judge said prosecutors failed to present enough evidence to charge Insys founder John Kapoor on conspiracy in the drugmaker's Subsys sales.
As Insys reaches the last days of its bankruptcy liquidation, it's offering to settle its opioid overhang at pennies on the dollar for plaintiffs.
1. Reckitt Benckiser—$1.4 billion
Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.
Mallinckrodt is getting burned on all sides for its marketing and price hikes for H.P. Achtar Gel. Now, a major U.S. insurer wants to pile on.
Teva’s $519 million settlement with the U.S. government in 2016 was meant to clear its name. Now, former leaders will foot their end of the bargain.